SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001640334-19-000914
Filing Date
2019-05-17
Accepted
2019-05-17 16:57:19
Documents
7
Effectiveness Date
2019-05-17

Document Format Files

Seq Description Document Type Size
1 FORM S-8 lxrp_s8.htm S-8 48062
2 EX-4.1 lxrp_ex41.htm EX-4.1 69666
3 EX-5.1 lxrp_ex51.htm EX-5.1 7652
4 EX-23.2 lxrp_ex232.htm EX-23.2 1937
5 lxrp_ex51img1.jpg GRAPHIC 10581
6 lxrp_ex232img1.jpg GRAPHIC 12720
7 lxrp_ex232img4.jpg GRAPHIC 8743
  Complete submission text file 0001640334-19-000914.txt   172965
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: S-8 | Act: 33 | File No.: 333-231585 | Film No.: 19836543
SIC: 1000 Metal Mining